Research programme: immunotherapeutic cancer vaccines - InvectysAlternative Names: INMAB-1
Latest Information Update: 10 Mar 2016
At a glance
- Originator Invectys
- Class Cancer vaccines; DNA vaccines; Monoclonal antibodies; Subunit vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 10 Mar 2016 Preclinical trials in Cancer in France (Parenteral)
- 03 Dec 2014 Early research in Cancer in France (Parenteral)